Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy

• Status: Not yet recruiting
• Trial end date: 2022-04-01
• Target enrollment: 0
• Participant gender: All

Summary

In this randomized placebo-controlled clinical trial, patients will be randomized to be administered viscous lidocaine or placebo preoperatively to elective upper endoscopy

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bispebjerg Hospital
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Patients referred to and found fit for upper GI endoscopy in an out patient setting

• Between 18 and 75 years old

• Speaks and understands Danish

Exclusion Criteria:

• Patients admitted for upper GI endoscopy in an in-patient setting

• Patients with dementia and/or other cognitive dysfunction disorders

• Patients primarily complaining of dysphagia

• Patients allergic to lidocaine

• Patients with suspected retention

• Patients who will undergo upper GI endoscopy with nurse-assisted propofol sedation

• Patients who will undergo upper GI endoscopy with assistance of anesthesia-personnel